3Marting G,Dues H,Blanquart C,et al.Statin-induced inhibition of the Rhosignaling pathway activates PPARa and induces HDL apoA-I[].The Journal of Clinical Investigation.2006
2Giroud D, Li JM, Urban P, Meiar B,Rutishauer W. Relation of the site of acute myocardial infarction to the most severe coronary arterial stenosis at prior angiography.Am J Cardiol,1992,69:729-732
3Jorge P.Inflammatory pathways in atherosclerosis and acute coronary syndromes. AM J Cantiol, 2001, 88 (suppl): 10k-15k.
4Chandler WL, Suatton JR.Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.Am J Clin Pathol,1994,102:248-252
5Bhakdi S, Torzewski M, Klouche M, Hemmes M. Complement and atherogenesis: binding of CRP to degraded nonaxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol, 1999, 19:2 348-354.
6Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflamnation in the prediction of cardiovascular disease in women.N Engl J Med, 2000, 342:836-843.
8Li D, Zhao L, Liu M, Du X, Ding W, Zhang J, et al.Kinetics of tumor necrosis factor alpha in plasma and the cardioprotective effect of a monoclonal antibody to tumor necrosis factor alpha in acute myocardial infarction.Am Heart J,1999, 137:1 145-152.
9Koch W, Kastrati A, Bottiger C, Mehilli J,von Beckerath N, Schmig A. Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction.Atherasclerosis, 2001,159: 137-144.
10Bogaty P, Poirier P, Simard S, Boyer L, Solymoss S, Dagenais GR. Biological Profiles in subjects with recurrent acute coronary events compared with subjects with long-standing stable angina.Circulation, 2001, 103 (25) : 3 052-065.
